ImmunoGen

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunoGen and other ETFs, options, and stocks.

About IMGN

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. 

CEO
Mark Joseph Enyedy
CEOMark Joseph Enyedy
Employees
106
Employees106
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1981
Founded1981
Employees
106
Employees106

IMGN Key Statistics

Market cap
1.04B
Market cap1.04B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.96M
Average volume2.96M
High today
$4.88
High today$4.88
Low today
$4.63
Low today$4.63
Open price
$4.73
Open price$4.73
Volume
2.36M
Volume2.36M
52 Week high
$7.77
52 Week high$7.77
52 Week low
$3.10
52 Week low$3.10

Analyst ratings

70%

of 10 ratings
Buy
70%
Hold
30%
Sell
0%

IMGN Earnings

-$1.71
-$1.09
-$0.46
$0.16
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 28, Pre-Market
ActualExpected Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.